These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
543 related items for PubMed ID: 9030116
1. Dormancy, drug resistance or dependency; some thoughts to ponder. Shetty VP, Mistry NF, Uplekar MW, Antia NH, Pai VV, Ganapati R. Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116 [No Abstract] [Full Text] [Related]
2. Does dapsone resistance really matter in the MDT era? Ji B. Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322 [No Abstract] [Full Text] [Related]
3. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance. Waters MF, Pearson JM, Rees RJ. Int J Lepr Other Mycobact Dis; 1976 Mar; 44(1-2):152-3. PubMed ID: 776850 [No Abstract] [Full Text] [Related]
5. Drug resistance in leprosy: lessons from past and future perspective. Gupta UD, Katoch VM. Indian J Lepr; 1999 Mar; 71(4):451-63. PubMed ID: 10804973 [Abstract] [Full Text] [Related]
6. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. Cambau E, Carthagena L, Chauffour A, Ji B, Jarlier V. Clin Infect Dis; 2006 Jan 15; 42(2):238-41. PubMed ID: 16355335 [Abstract] [Full Text] [Related]
8. Concepts behind the development of multiple drug therapy regimens in leprosy. Waters MF. Lepr Rev; 1986 Dec 15; 57 Suppl 1():61-7. PubMed ID: 3295437 [No Abstract] [Full Text] [Related]
9. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Matsuoka M, Kashiwabara Y, Namisato M. Int J Lepr Other Mycobact Dis; 2000 Dec 15; 68(4):452-5. PubMed ID: 11332288 [Abstract] [Full Text] [Related]
12. Search for effective short-course regimens for the treatment of leprosy. Pattyn SR. Int J Lepr Other Mycobact Dis; 1993 Mar 15; 61(1):76-81. PubMed ID: 8326183 [No Abstract] [Full Text] [Related]
13. Committee 4: workshop on experimental chemotherapy of leprosy. Int J Lepr Other Mycobact Dis; 1979 Jun 15; 47(2 Suppl):297-303. PubMed ID: 378876 [No Abstract] [Full Text] [Related]
14. Primary dapsone resistant Mycobacterium leprae in a non endemic country. Jamil A, Noor NM, Osman AS, Baseri MM, Muthupalaniappen L. Indian J Dermatol Venereol Leprol; 2013 Jun 15; 79(4):527-9. PubMed ID: 23760326 [No Abstract] [Full Text] [Related]
16. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era. Gupta UD, Katoch K, Katoch VM. Indian J Lepr; 2009 Jun 15; 81(3):131-4. PubMed ID: 20509341 [Abstract] [Full Text] [Related]
17. Primary dapsone resistance in Cebu, The Philippines; cause for concern. dela Cruz E, Cellona RV, Balagon MV, Villahermosa LG, Fajardo TT, Abalos RM, Tan EV, Walsh GP. Int J Lepr Other Mycobact Dis; 1996 Sep 15; 64(3):253-6. PubMed ID: 8862258 [Abstract] [Full Text] [Related]
18. Dapsone resistance in Mycobacterium leprae. Gillis TP, Williams DL. Lepr Rev; 2000 Dec 15; 71 Suppl():S91-5. PubMed ID: 11201896 [Abstract] [Full Text] [Related]
19. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India. Ebenezer GJ, Norman G, Joseph GA, Daniel S, Job CK. Indian J Lepr; 2002 Dec 15; 74(4):301-12. PubMed ID: 12624978 [Abstract] [Full Text] [Related]
20. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK, Bhatia VN, Harikrishnan S. Int J Lepr Other Mycobact Dis; 1986 Sep 15; 54(3):389-91. PubMed ID: 3528345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]